fbpx

Written by 12:00 Analys, Research

GRANGEX: Final regulatory hurdle cleared to materialise the world’s first CO2-free iron ore mine

GRÄNGESBERG EXPLORATION The Land and Environmental Court has now granted GRANGEX the permit for mining operations at Dannemora, meaning that no regulatory hurdles remains. Next steps are now to complete the financing, and continue the procurement and preparations for the start of construction in the autumn with a planned start of production in 2025. Along with the offtake agreement with Anglo American signed in March, GRANGEX has now taken two major steps to de-risk the case, which combined with a slight mix change in the upcoming SEK 1.9bn financing, motivate a hike in our fair value to SEK 80-150 (72-94) in 12-24 months.


Johan Widmark | 2023-06-26 12:00 

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research report has not been prepared in accordance with legal requirements designed to promote the independence of investment research and Emergers is not subject to any prohibition on dealing ahead of the dissemination of investment research. This research does not constitute investment advice and is not a solicitation to buy shares. For more information, please refer to disclaimer.  
 

Last regulatory hurdle cleared

Through its wholly owned subsidiary Dannemora Iron AB, GRANGEX has now, in less than a year from submitting the application, received approval for its environmental impact assessment and permit for mining and water operations at the Dannemora mine. As there were no reservations or supplements, there are no more regulatory hurdles to pass in order to start mining operations at Dannemora. This also means that the risk from an investor perspective has been reduced significantly.  

Clear roadmap to production start in H1’25

With this announcement, GRANGEX now enters the construction phase where the key events will be to empty the mine of water, make room for the new underground crusher, and continue the procurement and preparations for the start of construction.

Simultaneously, GRANGEX will need to complete the financing for the construction phase. We now expect the company to raise another SEK 1.9bn in Q3’23 in a mix of SEK 500m in new equity and SEK 1400m in a mix of co-investments from strategic investors, project financing and secured debt. This is a slightly different volume and mix than the our previous estimate of SEK 1.8bn (SEK 300m in new equity and SEK 1500m in debt), after the SEK 100m capital injection from Anglo American.

At this point however, it is still uncertain what the final structure will look like, but it will likely affect the Levered Equity Value for GRANGEX’s current shareholders. All in all, we still find support for an Unlevered Net Present Value largely in line with the NPV presented in the company’s DFS. Given the completion of the financing during H2’23, we expect production start in H1’25.

Major de-risking motivate a hike in fair value

Looking at valuation potential for equity investors, we continue to find support for an Unlevered NPV for Dannemora of SEK 2.2bn after tax. With a 13% return requirement for equity investors, and 8% interest for debt holders, the updated mix gives a 8.1% (7.4%) WACC in our unlevered DCF approach. The Unlevered approach gives a SEK 690m in Equity Value attributable to current shareholders. Applying a Levered DCF after tax approach, using only the Cost of Equity (13%) as discount rate, this gives SEK 762m attributable to current shareholders.

Moreover, current iron ore prices suggest a price of USD 150+/t for 68% iron ore (USD 136/t for 65% plus USD 8 for each additional ppt) , which is above ours and the company’s USD 129/t model estimate. And with a strong structural support for rising prices for high grade iron ore, and SEK +650m in additional NPV for each USD +10 in iron ore prices above USD 129/t, we find considerable further valuation upside with rising prices. All in all, we now find support for a fair value of around SEK 80-150 (72-94) per share in 12-24m.

DISCLAIMER

This commissioned research report is for informational purposes only and is to be considered marketing communication. This research does not constitute investment advice and is not a solicitation to buy shares. Information provided here or on Emergers’ website emergers.se is not intended to be financial advice. This research shall not be construed as a recommendation or solicitation to invest in the companies described. Emergers cannot be held liable for either direct or indirect damages caused by decisions made on the basis of information in this analysis. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

This material is not intended to be financial advice. This material has been commissioned by the Company in question and prepared and issued by Emergers, in consideration of a fee payable by the Company. Emergers charges a standard fee for the production and broad dissemination of a detailed note following by regular update notes. Fees are paid upfront in cash without recourse. Emergers may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained herein represent those of the research analyst at Emergers at the time of publication. The company has been given the opportunity to influence factual statements before publication, but forecasts, conclusions and valuation reasoning are Emergers’ own. Forward-looking information or statements contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Emergers shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained in this material.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Emergers’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in this material may not be eligible for sale in all jurisdictions or to certain categories of investors. Investors are encouraged to seek additional information as well as consult a financial advisor prior to any investment decision.

Investment in securities mentioned: Emergers has a restrictive policy relating to personal dealing and conflicts of interest. Emergers does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Emergers may have a position in any or related securities mentioned in this report, subject to Emergers’ policies on personal dealing and conflicts of interest.

Copyright: Copyright 2023 Incirrata AB (Emergers)

United Kingdom
This document is prepared and provided by Emergers for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the ”FPO”) (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States
Emergers relies upon the ”publishers’ exclusion” from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Emergers does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

Read Less Read More

For new research on growth stocks, sign up to our newsletter